Search
Press Release / Nov 11, 2004
FDA inspects Hovione's API manufacturing plant in Macau
Hovione's active pharmaceutical ingredients plant in Macau underwent a pre-approval inspection by FDA
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione's active pharmaceutical ingredients plant in Macau underwent a pre-approval inspection by FDA